tiprankstipranks
Trending News
More News >
Serina Therapeutics (SER)
:SER
US Market

Serina Therapeutics (SER) Financial Statements

Compare
226 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently $28.47M. The company's EPS TTM is $-0.45; its P/E ratio is -0.45; Serina Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 56.00K$ 3.15M$ 500.00K$ 3.04M$ 54.00K
Gross Profit$ -138.00K$ 3.06M$ 500.00K$ 3.04M$ -1.23M
Operating Income$ -17.05M$ -3.13M$ -2.27M$ -1.63M$ -10.41M
EBITDA$ -10.49M$ 5.92M$ -2.60M$ -1.23M$ -8.74M
Net Income$ -11.14M$ 5.27M$ -2.68M$ -1.26M$ -10.87M
Balance Sheet
Cash & Short-Term Investments$ 3.67M$ 7.62M$ 645.00K$ 584.00K$ 527.00K
Total Assets$ 6.72M$ 8.97M$ 3.24M$ 3.15M$ 3.92M
Total Debt$ 268.00K$ 3.44M$ 18.12M$ 13.20M$ 6.30M
Net Debt$ -3.40M$ -4.17M$ 17.48M$ 12.62M$ 5.77M
Total Liabilities$ 6.22M$ 41.26M$ 20.56M$ 15.03M$ 9.32M
Stockholders' Equity$ 641.00K$ -32.29M$ -17.21M$ -11.83M$ -5.12M
Cash Flow
Free Cash Flow$ -17.16M$ -2.98M$ -2.09M$ -2.36M$ -7.84M
Operating Cash Flow$ -17.14M$ -2.48M$ -2.08M$ -2.25M$ -7.82M
Investing Cash Flow$ -22.00K$ -504.00K$ 980.94K$ 823.32K$ -20.00K
Financing Cash Flow$ 13.21M$ 10.07M$ 1.31M$ 1.08M$ 5.96M
Currency in USD

Serina Therapeutics Earnings and Revenue History

Serina Therapeutics Debt to Assets

Serina Therapeutics Cash Flow

Serina Therapeutics Forecast EPS vs Actual EPS